share_log

ネクセラファーマ:当社提携先であるニューロクライン社による健常成人を対象としたNBI-1117567の第1相臨床試験開始のお知らせ

Sosei Group: Notice of commencement of phase 1 clinical trial of NBI-1117567 targeting healthy adults by Neurocline, our partner

JPX ·  May 9 02:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more